Ultrasonic-Controlled Drug Release Prevents Protumorigenic Transition and Improves Sequential Targeting Effect to Enhance Treatment of Residual Hepatocellular Carcinoma
Biomaterials Research · 2025-01 · 29
DOI: 10.34133/bmr.0114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 29.01.2025. Verfasst von Yongquan Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Youth Program of National Natural Science Foundation of Chinaal Natural Science Foundation of China, National Natural Science Foundation of China, Guangdong basic and applied basic research project.
Abstract (Originalsprache)
Insufficient radio-frequency ablation (IRFA) of hepatocellular carcinoma accelerates the recurrence of residual tumor, leading to a poor prognosis. Neutrophils (NEs), as the initial leukocytes to infiltrate the IRFA-associated inflammatory area, were utilized as drug carriers due to their inherent chemotactic properties for targeted delivery of chemotherapy drugs to the inflammatory site where residual tumor persists post-IRFA. Previous research has highlighted that the immunosuppressive cytokines in the tumor microenvironment could promote the transition of NEs into a protumorigenic phenotype. However, it is unclear whether NEs used as drug delivery carriers undergo similar changes and how this transition affects treatment effectiveness. Here, we present novel findings demonstrating the phenotypic transition of NEs in the residual tumor microenvironment from an antitumorigenic to a protumorigenic state following IRFA treatment. More critically, we found for the first time that NE carriers undergo a comparable phenotypic transition in the residual tumor, thereby attenuating the therapeutic outcome. Ingeniously, coloading NE carriers with perfluorohexane not only enabled ultrasound imaging but also facilitated spatiotemporally controllable drug release through ultrasound irradiation, thus preventing the protumorigenic transition of NE carriers and maintaining an inflammatory microenvironment at the residual tumor zone. This significantly improved the sequential targeting effect of NE carriers and ultimately enhanced the treatment of residual tumor post-IRFA. Our study provided novel insights into the modulatory role of the immune microenvironment on the phenotypic transition of live NE carriers in the drug delivery system and presented a strategy to prevent adverse effects and enhance residual tumor treatment.
Autor:innen und Institutionen
- Department of Ultrasound, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China.
- Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province 519000…
- Center of Cardiovascular Disease, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China.
ORCID-Profile: Zhongzhen Su
Förderung
- the Youth Program of National Natural Science Foundation of Chinaal Natural Science Foundation of China
- National Natural Science Foundation of China
- Guangdong basic and applied basic research project
- Zhuhai basic and applied basic research project
- the Guangdong Basic and Applied Basic Research Fund Regional Joint Fund - Youth Fund Project
- Scientific research project of Traditional Chinese Medicine Bureau of Guangdong Province
- Zhuhai social development field science and technology plan project
- Excellent Young Researchers Program of the 5th Affiliated Hospital of SYSU
Zitieren
APA
Huang, Y., Pi, S., Chen, H., Zhang, S., Xian, J., Lin, Y., Chen, J., Ye, Q., Ye, F., Huang, Y., Yu, H., & Su, Z. (2025). Ultrasonic-Controlled Drug Release Prevents Protumorigenic Transition and Improves Sequential Targeting Effect to Enhance Treatment of Residual Hepatocellular Carcinoma. Biomaterials Research, 29. https://doi.org/10.34133/bmr.0114
Vancouver
Huang Y, Pi S, Chen H, Zhang S, Xian J, Lin Y, et al. Ultrasonic-Controlled Drug Release Prevents Protumorigenic Transition and Improves Sequential Targeting Effect to Enhance Treatment of Residual Hepatocellular Carcinoma. Biomaterials Research. 2025;29. doi:10.34133/bmr.0114
BibTeX
@article{Huang2025,
author = {Huang, Yongquan and Pi, Songying and Chen, Hui and Zhang, Shushan and Xian, Jianzhong and Lin, Yuhong and Chen, Jiaxing and Ye, Qing and Ye, Feile and Huang, Yin and Yu, Hailing and Su, Zhongzhen},
title = {Ultrasonic-Controlled Drug Release Prevents Protumorigenic Transition and Improves Sequential Targeting Effect to Enhance Treatment of Residual Hepatocellular Carcinoma},
journal = {Biomaterials Research},
year = {2025},
volume = {29},
doi = {10.34133/bmr.0114}
}
EUVIMED